Legend Biotech LEGN
NASDAQ LEGN
$18.82 +0.20 (+1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Non-Current Debt (2021 - 2025)

Updated

Legend Biotech's Non-Current Debt was $63 million in FY2019, compared with -$86.94 million in FY2018.

Analysis

Legend Biotech (LEGN) Non-Current Debt (2021 - 2025) Analysis & Trends

  • Per Business Quant data, Non-Current Debt in earlier years was -$86.94 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Legend Biotech 3.43 Bn -308.34 Mn 251.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 142.87 Mn
Jun 30, 2025 310.26 Mn
Mar 31, 2025 305.75 Mn
Dec 31, 2024 301.20 Mn
Sep 30, 2024 296.62 Mn
Jun 30, 2024 291.56 Mn
Mar 31, 2024 286.40 Mn
Dec 31, 2023 281.33 Mn
Sep 30, 2023 275.91 Mn
Jun 30, 2023 270.61 Mn
Mar 31, 2023 265.86 Mn
Dec 31, 2022 260.93 Mn
Mar 31, 2022 126.71 Mn
Dec 31, 2021 120.46 Mn
Sep 30, 2021 70.54 Mn
Jun 30, 2021 17.31 Mn
API Access

Legend Biotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LEGN&period=max&api_key=YOUR_API_KEY